183 related articles for article (PubMed ID: 2502417)
21. Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.
Maher VM; Gallagher JJ; Thompson GR; Myant NB
Atherosclerosis; 1991 Nov; 91(1-2):73-6. PubMed ID: 1811555
[TBL] [Abstract][Full Text] [Related]
22. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
Geisel J; Oette K; Burrichter H
Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
[TBL] [Abstract][Full Text] [Related]
23. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027
[TBL] [Abstract][Full Text] [Related]
24. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A
Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
[TBL] [Abstract][Full Text] [Related]
25. Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia.
Simons LA; Sullivan D; Simons J; Celermajer DS
Atherosclerosis; 1998 Mar; 137(1):197-203. PubMed ID: 9568752
[TBL] [Abstract][Full Text] [Related]
26. Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study.
Keech A; Collins R; MacMahon S; Armitage J; Lawson A; Wallendszus K; Fatemian M; Kearney E; Lyon V; Mindell J
Eur Heart J; 1994 Feb; 15(2):255-69. PubMed ID: 8005129
[TBL] [Abstract][Full Text] [Related]
27. Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.
Farrer M; Winocour PH; Evans K; Neil HA; Laker MF; Kesteven P; Alberti KG
Diabetes Res Clin Pract; 1994 Mar; 23(2):111-9. PubMed ID: 8070302
[TBL] [Abstract][Full Text] [Related]
28. [Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia].
Aubert I; Emmerich J; Charpak Y; Chanu B; Dachet C; Herlich D; Besseau M; Rouffy J; Jacotot B
Presse Med; 1988 May; 17(18):901-4. PubMed ID: 2968595
[TBL] [Abstract][Full Text] [Related]
29. Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol.
Simons LA; Simons J; Parfitt A
Med J Aust; 1992 Oct; 157(7):455-9. PubMed ID: 1406395
[TBL] [Abstract][Full Text] [Related]
30. Simvastatin in severe hypercholesterolaemia: a placebo controlled trial.
McDowell IF; Smye M; Trinick T; Shortt JA; Archibald MP; Trimble ER; Nicholls DP
Br J Clin Pharmacol; 1991 Mar; 31(3):340-3. PubMed ID: 2054273
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
[TBL] [Abstract][Full Text] [Related]
32. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of simvastatin and cholestyramine on plasma lipoproteins and CETP in humans.
McPherson R
Can J Clin Pharmacol; 1999; 6(2):85-90. PubMed ID: 10519734
[TBL] [Abstract][Full Text] [Related]
34. Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients.
Lansberg PJ; Mitchel YB; Shapiro D; Kastelein JJ; Altman R; Jerums G; Bolzano K; Giannini S; Davignon J; DeWailly P
Atherosclerosis; 1995 Aug; 116(2):153-62. PubMed ID: 7575771
[TBL] [Abstract][Full Text] [Related]
35. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
Bard JM; Ose L; Hagen E; Duriez P; Pfister P; Fruchart JC; Dallongeville J
Am J Cardiol; 1995 Jul; 76(2):65A-70A. PubMed ID: 7604802
[TBL] [Abstract][Full Text] [Related]
36. Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Jacob BG; Möhrle W; Richter WO; Schwandt P
Eur J Clin Pharmacol; 1992; 42(4):353-8. PubMed ID: 1516599
[TBL] [Abstract][Full Text] [Related]
37. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L
Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429
[TBL] [Abstract][Full Text] [Related]
38. Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia.
Wierzbicki AS; Lumb PJ; Cheung J; Crook MA
QJM; 1997 Oct; 90(10):631-4. PubMed ID: 9415344
[TBL] [Abstract][Full Text] [Related]
39. Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.
Hagen E; Istad H; Ose L; Bodd E; Eriksen HM; Selvig V; Bard JM; Fruchart JC; Borge M; Wolf MC
Eur J Clin Pharmacol; 1994; 46(5):445-9. PubMed ID: 7957541
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.
Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI
Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
